New bioactive compounds from the marine-derived actinomycete Nocardiopsis lucentensis sp. ASMR2
Essam M. Eliwa,Ahmed S. Abdel-Razek,Marcel Frese,Daniel Wibberg,Ahmed H. Halawa,Ahmed M. El-Agrody,Ahmed H. Bedair,Jörn Kalinowski,Norbert Sewald,Mohamed Shaaban
DOI: https://doi.org/10.1515/znb-2016-0250
2017-04-26
Zeitschrift für Naturforschung B
Abstract:Abstract In the search for new bioactive compounds from extremophilic actinomycetes, a new marine actinomycete strain, Nocardiopsis lucentensis sp. ASMR2 has been isolated and taxonomically identified from marine plants collected in the Red Sea at Hurghada coasts. A large-scale fermentation of the strain on modified rice solid medium was performed, followed by work-up and purification of the obtained extract using a series of chromatographic purifications, delivering the novel butenolide system 3′-hydroxy- N -(2-oxo-2,5-dihydrofuran-4-yl)propionamide ( 1a ) along with the naturally new 4-methoxy-2 H -isoquinolin-1-one ( 2 ). Furthermore, eight known bioactive compounds are also reported, namely, indole-3-carboxylic acid, indole-3-acetic acid, indole-3-acetic acid methyl ester, furan-2,5-dimethanol, tyrosol, glycerol linoleate, cyclo-(Tyr, Pro), and adenosine. The chemical structures of the new compounds ( 1a , 2 ) were confirmed by extensive one- and two-dimensional (1D and 2D) nuclear magnetic resonance (NMR) spectroscopy, electron ionization high resolution (EI-HR) mass spectrometry, and by comparison with literature data. The antimicrobial activity of the strain extract, as well as of compounds 1a and 2 , were studied using a panel of pathogenic microorganisms. The in vitro cytotoxicity of the bacterial extract and compounds 1a and 2 were studied against the human cervix carcinoma cell line (KB-3-1) and its multidrug-resistant subclone (KB-V1).